Growth hormone replacement is important for the restoration of parathyroid hormone sensitivity and improvement in bone metabolism in older adult growth hormone-deficient patients

Journal of Clinical Endocrinology and Metabolism

Volumn 90, Issue 6, 2005, Pages 3371-3380

  White, H D ^a   Ahmad, A M ^a   Durham, B H ^a   Patwala, A ^a   Whittingham, P ^a   Fraser, W D ^a   Vora, J P ^a  

^a ROYAL LIVERPOOL UNIVERSITY HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM; CARBOXY TERMINAL TELOPEPTIDE; COLLAGEN TYPE 1; CYCLIC AMP; GROWTH HORMONE; PARATHYROID HORMONE; PHOSPHATE; PROCOLLAGEN; HUMAN GROWTH HORMONE;

ADULT; ADULT GROWTH HORMONE DEFICIENCY; AGE DISTRIBUTION; AGED; ARTICLE; BLOOD SAMPLING; BONE DENSITY; BONE METABOLISM; BONE TURNOVER; CIRCADIAN RHYTHM; CLINICAL ARTICLE; DRUG EFFICACY; FEMALE; GROWTH HORMONE DEFICIENCY; HORMONE SENSITIVITY; HORMONE SUBSTITUTION; HUMAN; MALE; PRIORITY JOURNAL; ADENOMA; BLOOD; BONE; HYPOPHYSIS TUMOR; METABOLISM; MIDDLE AGED; PROLACTINOMA; URINE;

ADENOMA; AGED; BONE AND BONES; CIRCADIAN RHYTHM; FEMALE; HORMONE REPLACEMENT THERAPY; HUMAN GROWTH HORMONE; HUMANS; MALE; MIDDLE AGED; PARATHYROID HORMONE; PHOSPHATES; PITUITARY NEOPLASMS; PROLACTINOMA;

EID: 21244441974     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.2004-1650     Document Type: Article

References (54)

1. Finkelstein JW, Roffwarg HP, Boyar RM, Kream J, Hellman L 1972 Agerelated change in the twenty-four-hour spontaneous secretion of growth hormone. J Clin Endocrinol Metab 35:665-670
2. Carlson HE, Gillin JC, Gorden P, Snyder F 1972 Absence of sleep-related growth hormone peaks in aged normal subjects and in acromegaly. J Clin Endocrinol Metab 34:1102-1105
3. Rudman D, Kutner MH, Rogers CM, Lubin MF, Fleming GA, Bain RP 1981 Impaired growth hormone secretion in the adult population: relation to age and adiposity. J Clin Invest 67:1361-1369
4. Shibasaki T, Shizume K, Nakahara M, Masuda A, Jibiki K, Demura H, Wakabayashi I, Ling N 1984 Age-related changes in plasma growth hormone response to growth hormone-releasing factor in man. J Clin Endocrinol Metab 58:212-214
5. Iranmanesh A, Lizarralde G, Veldhuis JD 1991 Age and relative adiposity are specific negative determinants of the frequency and amplitude of growth hormone (GH) secretory bursts and the half-life of endogenous GH in healthy men. J Clin Endocrinol Metab 73:1081-1088
6. Forbes GB, Reina JC 1970 Adult lean body mass declines with age: some longitudinal observations. Metabolism 19:653-663
7. Riggs BL, Wahner HW, Dunn WL, Mazess RB, Offord KP, Melton 3rd LJ 1981 Differential changes in bone mineral density of the appendicular and axial skeleton with aging: relationship to spinal osteoporosis. J Clin Invest 67:328-335
8. Rudman D 1985 Growth hormone, body composition, and aging. J Am Geriatr Soc 33:800-807
9. Cuneo RC, Salomon F, McGauley GA, Sonksen PH 1992 The growth hormone deficiency syndrome in adults. Clin Endocrinol (Oxf) 37:387-397
10. Toogood AA, O'Neill PA, Shalet SM 1996 Beyond the somatopause: growth hormone deficiency in adults over the age of 60 years. J Clin Endocrinol Metab 81:460-465
11. Toogood AA, Adams JE, O'Neill PA, Shalet SM 1997 Elderly patients with adult-onset growth hormone deficiency are not osteopenic. J Clin Endocrinol Metab 82:1462-1466
12. Rosen T, Hansson T, Granhed H, Szucs J, Bengtsson BA 1993 Reduced bone mineral content in adult patients with growth hormone deficiency. Acta Endocrinol (Copenh) 129:201-206
13. Raisz LG 1988 Local and systemic factors in the pathogenesis of osteoporosis. N Engl J Med 318:818-828
14. Eriksen EF, Kassem M, Langdahl B 1996 Growth hormone, insulin-like growth factors, and bone remodelling. Eur J Clin Invest 26:525-534
15. Wuster C, Abs R, Bengtsson BA, Bennmarker H, Feldt-Rasmussen U, Hernberg-Stahl E, Monson JP, Westberg B, Wilton P 2001 The influence of growth hormone deficiency, growth hormone replacement therapy, and other aspects of hypopituitarism on fracture rate and bone mineral density. J Bone Miner Res 16:398-405
16. Sartorio A, Conti A, Monzani M 1993 New markers of bone and collagen turnover in children and adults with growth hormone deficiency. Postgrad Med J 69:846-850
17. Salomon F, Cuneo RC, Hesp R, Sonksen PH 1989 The effects of treatment with recombinant human growth hormone on body composition and metabolism in adults with growth hormone deficiency. N Engl J Med 321:1797-1803
18. Jorgensen JO, Pedersen SA, Thuesen L, Jorgensen J, Ingemann-Hansen T, Skakkebaek NE, Christiansen JS 1989 Beneficial effects of growth hormone treatment in GH-deficient adults. Lancet 1:1221-1225
19. Bengtsson BA, Eden S, Lonn L, Kvist H, Stokland A, Lindstedt G, Bosaeus I, Tolli J, Sjostrom L, Isaksson OG 1993 Treatment of adults with growth hormone (GH) deficiency with recombinant human GH. J Clin Endocrinol Metab 76:309-317
20. Binnerts A, Swart GR, Wilson JH, Hoogerbrugge N, Pols HA, Birkenhager JC, Lamberts SW 1992 The effect of growth hormone administration in growth hormone deficient adults on bone, protein, carbohydrate and lipid homeostasis, as well as on body composition. Clin Endocrinol (Oxf) 37:79-87
21. Shalet SM 2000 GH deficiency in the elderly: the case for GH replacement. Clin Endocrinol (Oxf) 53:279-280
22. Lindsay R, Nieves J, Formica C, Henneman E, Woelfert L, Shen V, Dempster D, Cosman F 1997 Randomised controlled study of effect of parathyroid hormone on vertebral-bone mass and fracture incidence among postmenopausal women on oestrogen with osteoporosis. Lancet 350:550-555
23. Rouleau MF, Mitchell J, Goltzman D 1988 In vivo distribution of parathyroid hormone receptors in bone: evidence that a predominant osseous target cell is not the mature osteoblast. Endocrinology 123:187-191
24. Ahmad AM, Hopkins MT, Fraser WD, Ooi CG, Durham BH, Vora JP 2003 Parathyroid hormone secretory pattern, circulating activity, and effect on bone turnover in adult growth hormone deficiency. Bone 32:170-179
25. Ahmad AM, Thomas J, Clewes A, Hopkins MT, Guzder R, Ibrahim H, Durham BH, Vora JP, Fraser WD 2003 Effects of growth hormone replacement on parathyroid hormone sensitivity and bone mineral metabolism. J Clin Endocrinol Metab 88:2860-2868
26. Altman DG 1982 Statistics in medical journals. Stat Med 1:59-71
27. Gardner MD, Dryburgh FJ, Fyffe JA, Jenkins AS 1981 Predictive value of derived calcium figures based on the measurement of ionised calcium. Ann Clin Biochem 18 (Pt 2):106-109
28. White TF, Farndon JR, Conceicao SC, Laker MF, Ward MK, Kerr DN 198 Serum calcium status in health and disease: a comparison of measured and derived parameters. Clin Chem Acta 157:199-213
29. Walton RJ, Bijvoet OL 1975 Nomogram for derivation of renal threshold phosphate concentration. Lancet 2:309-310
30. Drezner MK, Neelon FA, Curtis HB, Lebovitz HE 1976 Renal cyclic adenosine monophosphate: an accurate index of parathyroid function. Metabolism 25:1103-1112
31. O'Reilly DS, Fraser WD, Penney MD, Logue FC, Cowan RA, Williams BC, Walters G 1986 Arginine infusion blocks the action of parathyroid hormone but not arginine vasopressin in the renal tubule in man. J Endocrinol 111:501-506
32. Blum WF, Breier BH 1994 Radioimmunoassays for IGFs and IGFBPs. Growth Regul 4(Suppl 1):11-19
33. Mojon A, Fernandez JR, Hermida RC 1992 Chronolab: an interactive software package for chronobiologic time series analysis written for the Macintosh computer. Chronobiol Int 9:403-412
34. Ahmad AM, Hopkins MT, Thomas J, Durham BH, Fraser WD, Vora JP 2004 Parathyroid responsiveness to hypocalcemic and hypercalcemic stimuli in adult growth hormone deficiency after growth hormone replacement. Am J Physiol Endocrinol Metab 286:986-993
35. Lieberman SA, Holloway L, Marcus R, Hoffman AR 1994 Interactions of growth hormone and parathyroid hormone in renal phosphate, calcium, and calcitriol metabolism and bone remodeling in postmenopausal women. J Bone Miner Res 9:1723-1728
36. Bouillon R, Okamura WH, Norman AW 1995 Structure-function relationships in the vitamin D endocrine system. Endocr Rev 16:200-257
37. Ahmad AM, Hopkins MT, Thomas J, Ibrahim H, Fraser WD, Vora JP 2001 Body composition and quality of life in adults with growth hormone deficiency; effects of low-dose growth hormone replacement. Clin Endocrinol (Oxf) 54:709-717
38. Bjork S, Jonsson B, Westphal O, Levin JE 1989 Quality of life of adults with growth hormone deficiency: a controlled study. Acta Paediatr Scand Suppl 356:55-59; discussion 60:73-74
39. Cuneo RC, Judd S, Wallace JD, Perry-Keene D, Burger H, Lim-Tio S, Strauss B, Stockigt J, Topliss D, Alford F, Hew L, Bode H, Conway A, Handelsman D, Dunn S, Boyages S, Cheung NW, Hurley D 1998 The Australian multicenter trial of growth hormone (GH) treatment in GH-deficient adults. J Clin Endocrinol Metab 83:107-116
40. McGauley GA 1989 Quality of life assessment before and after growth hormone treatment in adults with growth hormone deficiency. Acta Paediatr Scand Suppl 356:70 -72; discussion 73-74
41. Burman P, Broman JE, Hetta J, Wiklund I, Erfurth EM, Hagg E, Karlsson FA 1995 Quality of life in adults with growth hormone (GH) deficiency: response to treatment with recombinant human GH in a placebo-controlled 21-month trial. J Clin Endocrinol Metab 80:3585-3590
42. Calvo MS, Eyre DR, Gundberg CM 1996 Molecular basis and clinical application of biological markers of bone turnover. Endocr Rev 17:333-368
43. Fraser WD, Logue FC, Christie JP, Gallacher SJ, Cameron D, O'Reilly DS, Beastall GH, Boyle IT 1998 Alteration of the circadian rhythm of intact parathyroid hormone and serum phosphate in women with established postmenopausal osteoporosis. Osteoporos Int 8:121-126
44. Herfarth K, Schmidt-Gayk H, Graf S, Maier A 1992 Circadian rhythm and pulsatility of parathyroid hormone secretion in man. Clin Endocrinol (Oxf) 37:511-519
45. Ogle GD, Rosenberg AR, Kainer G 1992 Renal effects of growth hormone: II. Electrolyte homeostasis and body composition. Pediatr Nephrol 6:483-489
46. Weaver JU, Monson JP, Noonan K, Price C, Edwards A, Evans KA, James IT, Cunningham J 1996 The effect of low dose recombinant human growth hormone replacement on indices of bone remodelling and bone mineral density in adult growth hormone-deficient adults. Endocrinol Metab 3:55-61
47. Kann P, Piepkorn B, Schehler B, Andreas J, Lotz J, Prellwitz W, Beyer J 1998 Effect of long-term treatment with GH on bone metabolism, bone mineral density and bone elasticity in GH-deficient adults. Clin Endocrinol (Oxf) 48:561-568
48. Johannsson G, Rosen T, Bosaeus I, Sjostrom L, Bengtsson BA 1996 Two years of growth hormone (GH) treatment increases bone mineral content and density in hypopituitary patients with adult-onset GH deficiency. J Clin Endocrinol Metab 81:2865-2873
49. Bex M, Abs R, Maiter D, Beckers A, Lamberigts G, Bouillon R 2002 The effects of growth hormone replacement therapy on bone metabolism in adult-onset growth hormone deficiency: a 2-year open randomized controlled multicenter trial. J Bone Miner Res 17:1081-1094
50. Fernholm R, Bramnert M, Hagg E, Hilding A, Baylink DJ, Mohan S, Thoren M 2000 Growth hormone replacement therapy improves body composition and increases bone metabolism in elderly patients with pituitary disease. J Clin Endocrinol Metab 85:4104-4112
51. Toogood AA, Adams JE, O'Neill PA, Shalet SM 1996 Body composition in growth hormone deficient adults over the age of 60 years. Clin Endocrinol (Oxf) 45:399-405
52. Toogood AA, Jones J, O'Neill PA, Thorner MO, Shalet SM 1998 The diagnosis of severe growth hormone deficiency in elderly patients with hypothalamic-pituitary disease. Clin Endocrinol (Oxf) 48:569-576
53. Murray RD, Columb B, Adams JE, Shalet SM 2004 Low bone mass is an infrequent feature of the adult growth hormone deficiency syndrome in middle-age adults and the elderly. J Clin Endocrinol Metab 89:1124-1130
54. Monson JP, Abs R, Bengtsson BA, Bennmarker H, Feldt-Rasmussen U, Hernberg-Stahl E, Thoren M, Westberg B, Wilton P, Wuster C 2000 Growth hormone deficiency and replacement in elderly hypopituitary adults: KIMS Study Group and the KIMS International Board. Pharmacia and Upjohn International Metabolic Database. Clin Endocrinol (Oxf) 53:281-289